Recombinant Saccharomyces cerevisiae CTP-dependent diacylglycerol kinase 1 (DGK1)

What is Saccharomyces cerevisiae DGK1 and how does it function?

The Saccharomyces cerevisiae DGK1 gene encodes a diacylglycerol kinase enzyme that catalyzes the formation of phosphatidate (PA) from diacylglycerol (DAG) . The enzyme plays a critical role in phospholipid metabolism by converting DAG, a fusogenic lipid, to PA, which serves as an important intermediate in membrane phospholipid synthesis . Unlike mammalian diacylglycerol kinases, the yeast enzyme possesses the unique characteristic of utilizing CTP, rather than ATP, as the phosphate donor in the reaction . This CTP-dependent mechanism represents a fundamental difference in how yeast metabolizes lipid intermediates compared to other organisms.

What is the structural organization of DGK1?

DGK1 encodes a 32.8-kDa protein with distinct structural domains. The protein structure includes a short N-terminal hydrophilic region followed by four putative transmembrane domains . The latter portion contains a predicted CTP transferase domain that is characteristic of enzymes utilizing CTP as a substrate . This CTP transferase domain is shared with two other S. cerevisiae proteins: the CDS1-encoded CDP-DAG synthase and the SEC59-encoded dolichol kinase . Deletion analysis has demonstrated that the CTP transferase domain is sufficient for diacylglycerol kinase activity, highlighting its importance in enzyme function .

What are the optimal conditions for DGK1 enzymatic activity?

The DGK1-encoded enzyme exhibits specific biochemical properties:

The enzyme shows positive cooperative kinetics with respect to diacylglycerol with an apparent Km of 6.5 mol%, suggesting allosteric regulation in response to substrate concentration . With respect to CTP, the enzyme follows saturation kinetics with an apparent Km of 0.3 mM . Interestingly, dCTP functions both as a substrate (apparent Km = 0.4 mM) and as a competitive inhibitor (apparent Ki = 0.4 mM) of the enzyme .

How do mutations in the CTP transferase domain affect DGK1 activity?

Point mutations in conserved residues within the CTP transferase domain have been shown to abolish diacylglycerol kinase activity . Specifically, mutations R76A, K77A, D177A, and G184A result in complete loss of enzymatic function . These residues are likely critical for substrate binding or catalysis within the active site. The dependence of DGK1 function on these specific residues provides strong evidence that the in vivo functions of Dgk1p are specifically due to its diacylglycerol kinase activity rather than any secondary functions of the protein . This information is valuable for researchers designing experiments to examine structure-function relationships or creating functionally deficient mutants for phenotypic analysis.

What is the relationship between DGK1 and PAH1 in phospholipid homeostasis?

DGK1 and PAH1 function in an antagonistic manner to regulate phospholipid homeostasis:

• PAH1 encodes phosphatidate phosphatase, which converts PA to DAG, while DGK1 catalyzes the reverse reaction, converting DAG to PA .

• A dgk1Δ mutation bypasses the phenotypes caused by the pah1Δ mutation, which include elevated levels of PA, derepression of the INO1 gene, and nuclear/ER membrane expansion .

• Overexpression of DGK1 causes nuclear/ER membrane expansion phenotypes similar to those exhibited by cells carrying mutations in PAH1-encoded PA phosphatase activity .

This reciprocal relationship creates a regulatory circuit controlling the balance between PA and DAG, which are both critical lipid intermediates with distinct roles in membrane structure and function. The interplay between these enzymes allows yeast cells to fine-tune membrane phospholipid composition in response to changing physiological conditions or growth states .

What role does DGK1 play in triacylglycerol mobilization and growth?

In Saccharomyces cerevisiae, triacylglycerol mobilization for phospholipid synthesis occurs during growth resumption from stationary phase, and this metabolism is essential in the absence of de novo fatty acid synthesis . DGK1-encoded diacylglycerol kinase activity is required to convert triacylglycerol-derived diacylglycerol to phosphatidate for phospholipid synthesis . Cells lacking diacylglycerol kinase activity (dgk1Δ mutation) fail to resume growth in the presence of cerulenin, a fatty acid synthesis inhibitor .

Lipid analysis data has demonstrated that dgk1Δ mutant cells do not mobilize triacylglycerol for membrane phospholipid synthesis and instead accumulate diacylglycerol . This indicates that the conversion of DAG to PA by Dgk1 is a rate-limiting step in channeling triacylglycerol-derived DAG into phospholipid synthesis pathways during growth resumption, particularly when de novo fatty acid synthesis is compromised.

How does DGK1 influence membrane fusion events?

DGK1 functions as a negative regulator of vacuole fusion through the production of PA at the expense of depleting DAG . DAG is a fusogenic lipid that promotes membrane fusion, while PA can inhibit fusion events . The deletion of DGK1 (dgk1Δ) leads to a marked increase in vacuole fusion, which is attributed to elevated DAG levels . This enhancement in fusion is accompanied by increased resistance to the inhibitory effects of PA as well as inhibitors of Ypt7 activity, a key GTPase involved in the fusion process .

The regulatory role of Dgk1 in membrane fusion provides insight into how lipid metabolism can directly impact membrane dynamics and organelle morphology. By controlling the balance between DAG and PA, Dgk1 may serve as a molecular switch that determines whether membranes are primed for fusion or maintained as separate entities, thus influencing various membrane remodeling events in the cell.

What methods are most effective for studying DGK1 enzymatic activity?

The DAG kinase reaction can be effectively studied using radioisotope-based assays with [γ-³²P]CTP as the phosphate donor and dioleoyl-DAG as the lipid acceptor . Following the reaction, the chloroform-soluble product (phosphatidate) can be analyzed by thin-layer chromatography (TLC) and quantified by phosphorimaging analysis . This approach allows for the dose-dependent measurement of PA formation from CTP and DAG.

For optimal assay conditions:

• The enzyme reaction should be conducted at pH 7.0-7.5 with either Ca²⁺ or Mg²⁺ ions present .

• Reactions should be performed below 40°C to prevent enzyme denaturation .

• The inclusion of membrane phospholipids can stimulate activity, while avoiding CDP-diacylglycerol and sphingoid bases can prevent inhibition .

For overexpression and purification purposes, the galactose-inducible GAL1/10 promoter has been successfully used for DGK1 expression from high copy number plasmids (e.g., YEplac181-GAL1/10-DGK1), resulting in a massive increase in DAG kinase activity . The specific activity of DAG kinase in the membrane fraction of galactose-grown cells bearing this plasmid has been reported at approximately 130 ± 2.7 units/mg, representing a 7222-fold purification relative to wild-type cells .

How can researchers analyze the localization and dynamics of DGK1?

To study DGK1 localization and dynamics, researchers can employ both microscopy-based and biochemical approaches:

• Fluorescent protein tagging: Dgk1-GFP fusion proteins can be visualized in living cells using fluorescence microscopy. This approach has revealed the ribbon-like ER localization pattern as well as potential vacuolar association .

• Cell fractionation and immunoblotting: This method involves separating cellular components into crude lysate, cytosol, vacuoles, total membrane pool, and microsomes containing endoplasmic reticulum, followed by immunoblotting with anti-tag antibodies (e.g., anti-HA for Dgk1-HA) .

• Co-localization studies: Using vacuolar markers such as FM4-64 in conjunction with Dgk1-GFP allows for assessment of the degree of vacuole association .

• Enrichment markers: Ypt7 can serve as an enrichment marker for vacuoles, while Sec61 can be used as a marker for resident endoplasmic reticulum components when verifying fractionation quality .

These complementary approaches provide a comprehensive view of DGK1 localization and can help determine whether the enzyme's distribution changes under different physiological conditions or in response to genetic perturbations.

What expression systems are recommended for recombinant DGK1 production?

For recombinant expression of DGK1 in yeast, the galactose-inducible GAL1/10 promoter system has proven highly effective . This system allows for tight regulation of expression, with minimal expression in glucose-containing media and strong induction upon addition of galactose. Both low copy (YCplac111) and high copy (YEplac181) vectors containing GAL1/10-DGK1 constructs have been successfully employed .

For induction protocol:

• Grow cells to exponential phase (A₆₀₀ ~0.5) in synthetic medium with 2% raffinose as a carbon source.

• Add galactose to a final concentration of 2% to induce expression.

• Incubate for 24 hours to allow for maximal protein production .

This approach has yielded membrane preparations with DAG kinase specific activity of approximately 130 ± 2.7 units/mg, representing a 7222-fold increase over wild-type levels . This high level of expression facilitates biochemical characterization and is approximately 100-fold greater than the activities of other membrane-associated phospholipid synthesis enzymes in similar preparations .

What strategies can be used to study DGK1 structure-function relationships?

Several approaches have been successfully employed to investigate DGK1 structure-function relationships:

• Truncation mutants: Constructs such as DGK1Δ66, DGK1Δ70, and DGK1Δ77 have been used to determine the minimal functional domains required for activity .

• Site-directed mutagenesis: Point mutations in conserved residues (R76A, K77A, D177A, and G184A) have identified critical amino acids within the CTP transferase domain .

• Domain swapping: The CTP transferase domain shares similarities with those in SEC59-encoded dolichol kinase and CDS1-encoded CDP-diacylglycerol synthase, making it amenable to domain swapping experiments to determine specificity determinants .

• Promoter substitution: Replacing the native DGK1 promoter with regulatable promoters like GAL1/10 allows for controlled expression to study dosage effects .

These approaches, combined with enzymatic activity assays and phenotypic analyses, provide powerful tools for dissecting the molecular mechanisms underlying DGK1 function and regulation.

How is DGK1 activity regulated in response to changing metabolic conditions?

The regulation of DGK1 activity involves several mechanisms:

• Substrate availability: The positive cooperative kinetics with respect to diacylglycerol (Hill number = 2.5) suggests that the enzyme becomes more active as DAG concentrations increase, potentially serving as a feedback mechanism to prevent excessive DAG accumulation .

• Lipid effectors: DGK1 activity is stimulated by major membrane phospholipids and inhibited by CDP-diacylglycerol and sphingoid bases, indicating integration with broader lipid metabolic networks .

• Metabolic state: DGK1 function is particularly important during transitions between growth phases, especially during resumption from stationary phase when triacylglycerol stores are mobilized for membrane synthesis .

• Antagonistic relationship with PAH1: The opposing actions of DGK1 and PAH1 create a regulatory circuit that controls the balance between PA and DAG levels .

This multilayered regulation allows DGK1 to respond dynamically to cellular needs for phospholipid synthesis and membrane remodeling under different physiological conditions.

What are the consequences of DGK1 deletion or overexpression?

The deletion or overexpression of DGK1 results in distinct phenotypes:

DGK1 deletion (dgk1Δ):

• Failure to resume growth in the presence of cerulenin (fatty acid synthesis inhibitor)

• Inability to mobilize triacylglycerol for membrane phospholipid synthesis

• Accumulation of diacylglycerol

• Suppression of phenotypes associated with pah1Δ mutation

• Enhanced vacuole fusion attributed to elevated DAG levels

• Increased resistance to inhibitory effects of PA and inhibitors of Ypt7 activity

DGK1 overexpression:

• Nuclear/ER membrane expansion phenotype similar to that exhibited by cells with mutations in PAH1-encoded PA phosphatase activity

• Massive increase in DAG kinase activity (up to 7222-fold increase over wild-type levels)

• Potential reduction in DAG levels and increase in PA levels, affecting membrane fusion dynamics

These findings highlight the critical role of DGK1 in maintaining proper lipid homeostasis and membrane dynamics, with implications for understanding broader aspects of cellular physiology and adaptation to changing environmental conditions.

What are the current gaps in understanding DGK1 function?

Despite significant advances in characterizing DGK1, several knowledge gaps remain:

• The precise structural basis for CTP preference over ATP has not been fully elucidated.

• The mechanisms regulating DGK1 expression and activity in response to different growth conditions and stresses need further clarification.

• The complete interactome of DGK1, including potential protein-protein interactions that might modulate its function, remains to be established.

• The evolutionary significance of the CTP-dependent mechanism in yeast versus the ATP-dependent mechanism in other organisms requires additional comparative analysis.

What emerging technologies might advance DGK1 research?

Several cutting-edge approaches could significantly enhance our understanding of DGK1:

• Cryo-electron microscopy to determine the three-dimensional structure of DGK1 and its complexes

• Lipidomics to comprehensively analyze changes in lipid profiles in response to DGK1 manipulation

• Optogenetic approaches to achieve spatiotemporal control of DGK1 activity in living cells

• CRISPR-based screening to identify novel genetic interactions with DGK1

• Single-molecule imaging techniques to track DGK1 dynamics and interactions in real-time